Furthermore, FOXO3a as a target gene of miR-103, can boost metastasis downstream of PI3K/AKT prohibition in collaboration with the WNT/β-catenin pathway in colon cancer. This evidence concerns the gene AKT1 and malignant colon neoplasm.